XML 72 R41.htm IDEA: XBRL DOCUMENT
v3.25.4

SEGMENT REPORTING (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025
Segment Reporting [Abstract] |
Schedule of Segment Reporting Information, by Segment | The following table presents segment revenue and significant segment expenses (in thousands) for the years ended December 31, 2025 and 2024:
| YEAR ENDED DECEMBER 31,
| 2025 |  | 2024 |  |
REVENUE: |  |  |  |  |
Total segment revenue | $ | 244,061 |  |  | $ | 3,550 |  |  |
LESS: |  |  |  |  |
Rinvatercept program expenses | (7,081) |  |  | (16,090) |  |  |
Elritercept program expenses | (38,030) |  |  | (44,319) |  |  |
Cibotercept program expenses | (12,562) |  |  | (29,777) |  |  |
Preclinical & development expenses | (6,847) |  |  | (12,008) |  |  |
Compensation costs (excluding stock based compensation) | (45,331) |  |  | (48,084) |  |  |
Other external costs | (35,095) |  |  | (26,708) |  |  |
Other segment items3 | (12,101) |  |  | (13,917) |  |  |
Net income (loss) | $ | 87,014 |  |  | $ | (187,353) |  |  |

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration